The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort
Titel:
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort
Auteur:
Tariot, Pierre N. Lopera, Francisco Langbaum, Jessica B. Thomas, Ronald G. Hendrix, Suzanne Schneider, Lon S. Rios-Romenets, Silvia Giraldo, Margarita Acosta, Natalia Tobon, Carlos Ramos, Claudia Espinosa, Alejandro Cho, William Ward, Michael Clayton, David Friesenhahn, Michael Mackey, Howard Honigberg, Lee Sanabria Bohorquez, Sandra Chen, Kewei Walsh, Trisha Langlois, Carolyn Reiman, Eric M.
Verschenen in:
Alzheimer's & dementia. Translational research & clinical interventions